Found: 73
Select item for more details and to access through your institution.
Antiobesity pharmacotherapy in the management of type 2 diabetes.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Drug interactions of clinical importance with antihyperglycaemic agents: an update.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Diabetes is still a risk factor for restenosis after drug-eluting stent in coronary arteries.
- Published in:
- 2004
- By:
- Publication type:
- commentary
Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine.
- Published in:
- 1991
- By:
- Publication type:
- journal article
Decreased or increased insulin metabolism after glipizide in type II diabetes.
- Published in:
- 1988
- By:
- Publication type:
- Letter
U-100 insulin gives some protection against metabolic deterioration due to CSII interruption.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Prevention of metabolic alterations by insulin supplements administered either before or after 2-h nocturnal interruption of CSII.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Pharmacokinetic interactions with thiazolidinediones.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2010, v. 26, n. 7, p. 540, doi. 10.1002/dmrr.1114
- By:
- Publication type:
- Article
Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2009, v. 25, n. 6, p. 491, doi. 10.1002/dmrr.961
- By:
- Publication type:
- Article
Pulse pressure and cardiovascular autonomic neuropathy according to duration of type 1 diabetes.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2009, v. 25, n. 5, p. 442, doi. 10.1002/dmrr.969
- By:
- Publication type:
- Article
Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2007, v. 23, n. 5, p. 348, doi. 10.1002/dmrr.714
- By:
- Publication type:
- Article
Controversy about the cardiovascular safety of sibutramine.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Drug Interactions of Clinical Importance with Antihyperglycaemic Agents : An Update.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Tolerability Profile of Metformin/Glibenclamide Combination Tablets (Glucovance®): A New Treatment for the Management of Type 2 Diabetes Mellitus.
- Published in:
- Drug Safety, 2004, v. 27, n. 15, p. 1205, doi. 10.2165/00002018-200427150-00004
- By:
- Publication type:
- Article
Combined thiazolidinedione-insulin therapy: should we be concerned about safety?
- Published in:
- 2004
- By:
- Publication type:
- journal article
Combined Thiazolidinedione-Insulin Therapy.
- Published in:
- Drug Safety, 2004, v. 27, n. 12, p. 841, doi. 10.2165/00002018-200427120-00002
- By:
- Publication type:
- Article
Lipodystrophy Reactions to Insulin: Effects of Continuous Insulin Infusion and New Insulin Analogs.
- Published in:
- American Journal of Clinical Dermatology, 2007, v. 8, n. 1, p. 21, doi. 10.2165/00128071-200708010-00003
- By:
- Publication type:
- Article
Localization of insulinoma by intraoperative ultrasonography.
- Published in:
- 1989
- By:
- Publication type:
- Case Study
Localization of insulinoma by intraoperative ultrasonography.
- Published in:
- 1989
- By:
- Publication type:
- Letter
Pharmacokinetics of dipeptidylpeptidase-4 inhibitors.
- Published in:
- Diabetes, Obesity & Metabolism, 2010, v. 12, n. 8, p. 648, doi. 10.1111/j.1463-1326.2010.01212.x
- By:
- Publication type:
- Article
Oral Antidiabetic Agents: A Guide to Selection.
- Published in:
- Drugs, 1998, v. 55, n. 2, p. 225, doi. 10.2165/00003495-199855020-00004
- By:
- Publication type:
- Article
Body image discrepancy and subjective norm as mediators and moderators of the relationship between body mass index and quality of life.
- Published in:
- Patient Preference & Adherence, 2016, v. 10, p. 2261, doi. 10.2147/PPA.S112639
- By:
- Publication type:
- Article
SGLT2 Inhibitors as Add-On Therapy to Metformin for People with Type 2 Diabetes: A Review of Placebo-Controlled Trials in Asian versus Non-Asian Patients.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2020, v. 13, p. 2765, doi. 10.2147/DMSO.S193528
- By:
- Publication type:
- Article
When therapeutic drugs lead to diabetes.
- Published in:
- Diabetologia, 2022, v. 65, n. 5, p. 751, doi. 10.1007/s00125-022-05666-w
- By:
- Publication type:
- Article
Changes in pulse pressure, heart rate and the pulse pressure × heart rate product during squatting in Type 1 diabetes according to age.
- Published in:
- Diabetic Medicine, 2010, v. 27, n. 7, p. 753, doi. 10.1111/j.1464-5491.2010.03018.x
- By:
- Publication type:
- Article
Long-term glycaemic effects of pioglitazone compared with placebo as add-on treatment to metformin or sulphonylurea monotherapy in PROactive (PROactive 18).
- Published in:
- Diabetic Medicine, 2009, v. 26, n. 12, p. 1242, doi. 10.1111/j.1464-5491.2009.02857.x
- By:
- Publication type:
- Article
Long-term glycaemic control with metformin–sulphonylurea–pioglitazone triple therapy in PROactive (PROactive 17).
- Published in:
- Diabetic Medicine, 2009, v. 26, n. 10, p. 1033, doi. 10.1111/j.1464-5491.2009.02816.x
- By:
- Publication type:
- Article
Inhibiting or antagonizing glucagon: making progress in diabetes care.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 8, p. 720, doi. 10.1111/dom.12480
- By:
- Publication type:
- Article
Dapagliflozin: A Review of its Use in Type 2 Diabetes Mellitus.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
No Increased Insulin Sensitivity after a Single Intravenous Administration of a Recombinant Human Tumor Necrosis Factor Receptor: Fc Fusion Protein in Obese Insulin-Resistant Patients.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2000, v. 85, n. 3, p. 1316, doi. 10.1210/jcem.85.3.6417
- By:
- Publication type:
- Article
Parallel Reversibility of Biological Markers of the Metabolic Syndrome and Liver Steatosis after Gastroplasty-Induced Weight Loss in Severe Obesity.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1999, v. 84, n. 11, p. 4293, doi. 10.1210/jcem.84.11.6171-4
- By:
- Publication type:
- Article
Aspirin and clopidogrel resistance in patients with diabetes mellitus.
- Published in:
- European Heart Journal, 2006, v. 27, n. 23, p. 2900, doi. 10.1093/eurheartj/ehl295
- By:
- Publication type:
- Article
Drug-eluting stents: meta-analysis in diabetic patients.
- Published in:
- European Heart Journal, 2004, v. 25, n. 23, p. 2167, doi. 10.1016/j.ehj.2004.07.041
- By:
- Publication type:
- Article
CB1 Receptor Blockade and its Impact on Cardiometabolic Risk Factors: Overview of the RIO Programme with Rimonabant.
- Published in:
- Journal of Neuroendocrinology, 2008, v. 20, p. 139, doi. 10.1111/j.1365-2826.2008.01681.x
- By:
- Publication type:
- Article
Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System.
- Published in:
- Drugs, 2004, v. 64, n. 22, p. 2537, doi. 10.2165/00003495-200464220-00004
- By:
- Publication type:
- Article
Current Management Strategies for Coexisting Diabetes Mellitus and Obesity.
- Published in:
- Drugs, 2003, v. 63, n. 12, p. 1165, doi. 10.2165/00003495-200363120-00001
- By:
- Publication type:
- Article
Is There a Role for α-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus?
- Published in:
- Drugs, 2003, v. 63, n. 10, p. 933, doi. 10.2165/00003495-200363100-00002
- By:
- Publication type:
- Article
Effect of SGLT2 Inhibitors on the Sympathetic Nervous System and Blood Pressure.
- Published in:
- Current Cardiology Reports, 2019, v. 21, n. 8, p. N.PAG, doi. 10.1007/s11886-019-1165-1
- By:
- Publication type:
- Article
Preventing, Delaying, or Masking Type 2 Diabetes With Metformin in the Diabetes Prevention Program.
- Published in:
- Diabetes Care, 2003, v. 26, n. 9, p. 2701, doi. 10.2337/diacare.26.9.2701
- By:
- Publication type:
- Article
Potential pharmacokinetics interference between alpha-glucosidase inhibitors and other oral antidiabetic agents.
- Published in:
- 2002
- By:
- Publication type:
- commentary
Potential Pharmacokinetics Interference Between α-Glucosidase Inhibitors and Other Oral Antidiabetic Agents.
- Published in:
- Diabetes Care, 2002, v. 25, n. 1, p. 247, doi. 10.2337/diacare.25.1.247
- By:
- Publication type:
- Article
Troglitazone: Antihyperglycemic Activity and Potential Role in the Treatment of Type 2 Diabetes.
- Published in:
- Diabetes Care, 1999, v. 22, n. 9, p. 1568, doi. 10.2337/diacare.22.9.1568
- By:
- Publication type:
- Article
Anti-insulin antibodies and metabolic deterioration after interruption of continuous subcutaneous insulin infusion.
- Published in:
- 1986
- By:
- Publication type:
- Letter
Devices for the Treatment of Diabetes: Today.
- Published in:
- Artificial Organs, 1992, v. 16, n. 2, p. 163, doi. 10.1111/j.1525-1594.1992.tb00287.x
- By:
- Publication type:
- Article
Sodium–glucose cotransporter 2 inhibitors: renal outcomes according to baseline albuminuria.
- Published in:
- Clinical Kidney Journal, 2021, v. 14, n. 12, p. 2463, doi. 10.1093/ckj/sfab096
- By:
- Publication type:
- Article
Cardiovascular Risk-Benefit Profile of Sibutramine.
- Published in:
- American Journal of Cardiovascular Drugs, 2010, v. 10, n. 5, p. 321, doi. 10.2165/11584800-000000000-00000
- By:
- Publication type:
- Article
Author's reply to De Ponti et al.: "Pharmacokinetics in patients with chronic liver disease and hepatic safety of incretin-based therapies for the management of type 2 diabetes mellitus".
- Published in:
- 2015
- By:
- Publication type:
- commentary
Pharmacokinetics and clinical use of incretin-based therapies in patients with chronic kidney disease and type 2 diabetes.
- Published in:
- 2015
- By:
- Publication type:
- journal article